BioMarin Pharmaceutical Company Updates | Glassdoor

Company Updates

  • Our commitment to DE&I underscores our true belief that encouraging the voices from different backgrounds will enrich our work experiences, contribute to better decision making and ultimately, greatly benefit our patients.

  • We have furthered our reach into the development of cardiac gene therapies in a partnership with Swiss biotech DiNAQOR

  • We have been committed to the rare disease community and sustainbility for 22 years. Learn more about our commitment here:

  • Meet some of our MDs and PhDs and hear about their journey to science, medicine and BioMarin!

  • Get to know our gene therapy team. We’re committed to blazing the trail with research and treatments that help the rare disease community.

  • BioMarin has been ranked #4 on Forbes magazine's 2019 list of "America's Best Midsize Employers," and was ranked first among its peers in the ‘Drugs & Biotechnology’ industry! We’re proud of this year’s accomplishment and of our previous Forbes recognitions on its "Most Innovative Companies" and “World's Best Employers” lists. Read more about these achievements here:

    Forbes Names BioMarin 4th Best Midsize Employer in America

    SAN RAFAEL, Calif., April 17, 2019 / PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that it has been ranked fourth on Forbes magazine's 2019 list of "America's Best Midsize Employers," increasing from 51 st on last year's 2018 list. BioMarin was ranked first among its peers in the 'Drugs & Biotechnology' industry.

  • We consider ourselves #RareDisease research pioneers. Our employees are ambitious and determined, always breaking barriers and pushing boundaries in the hopes of discovering successful and life changing treatments. Join our team:

    Working at BioMarin

    Browse available job openings at BioMarin

  • Our cutting-edge research makes us unique while our goal to help the rare disease community brings us together. Watch to learn more about our research approach.

  • Did you know BioMarin built one of the first gene therapy manufacturing facilities in the world? Located in Novato, California, this site is home to our research pioneers.

  • We’re honored to receive our second recognition by Forbes as a best employer in 2018. This time on a global scale as one of “The World’s Best Employers 2018”!

    Forbes Names BioMarin Among World's Best Employers

    SAN RAFAEL, Calif., Oct. 11, 2018 / PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that Forbes' named the company to its list, Global 2000: World's Best Employers. It is ranked within the top 300 out of a total of 2000 companies and fifth among the nine biotech companies also named.

Work at BioMarin Pharmaceutical? Share Your Experiences

BioMarin Pharmaceutical
  • Star
  • Star
  • Star
  • Star
  • Star
Click to Rate